BackPharma sales remain flat, grow 0.2% in Jul
The fall in sales of acute therapy drugs indicates that people are avoiding visiting doctors at clinics and hospitals
PremiumNEW DELHI : Medicine sales in India were almost flat in July on a year-on-year basis although it has recovered since the March to May period when the country was under a strict lockdown, showed data from market researcher AIOCD-AWACS.
July drug sales were up 0.2% y-o-y to ₹12,124 crore, with cardiac care and anti-diabetic drugs posting healthy growth, albeit at a slower pace compared to June. Growth was on account of chronic medicines as sale of acute therapies remained suppressed. Sale of cardiovascular drugs were up 13.1%, at a slightly slower growth rate compared to 13.9% in June, while anti-diabetic drugs posted 5.9% growth compared to 8.5% in the preceding month.
However, anti-infectives continued to stay in the red for the fourth straight month, down 10.2%. Sales of another acute therapy segment, gastrointestinal drugs, also declined 2.4%.
The fall in sales of acute therapy drugs indicates that people are avoiding visiting doctors at clinics and outpatient departments of hospitals, with the fear of contracting coronavirus.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
